ArticleLeukemia2013

Bcl-xL anti-apoptotic network is dispensable for development and maintenance of CML but is required for disease progression where it represents a new therapeutic target.

J G Harb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.